Page last updated: 2024-08-25

narciclasine and Brain Neoplasms

narciclasine has been researched along with Brain Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Evidente, A; Kiss, R; Kornienko, A; Lefranc, F; Mathieu, V; Van Goietsenoven, G	1

Reviews

1 review(s) available for narciclasine and Brain Neoplasms

Article	Year
Narciclasine as well as other Amaryllidaceae isocarbostyrils are promising GTP-ase targeting agents against brain cancers. Medicinal research reviews, 2013, Volume: 33, Issue:2 Topics: Amaryllidaceae Alkaloids; Animals; Apoptosis; Brain Neoplasms; Cohort Studies; Cytotoxins; Disease Models, Animal; Dose-Response Relationship, Drug; Glioblastoma; GTP Phosphohydrolases; Humans; In Vitro Techniques; Melanoma; Mice; Molecular Targeted Therapy; Neoplasms; Phenanthridines; Structure-Activity Relationship; Transplantation, Heterologous; Treatment Outcome	2013

Article

Year

Narciclasine as well as other Amaryllidaceae isocarbostyrils are promising GTP-ase targeting agents against brain cancers.

Medicinal research reviews, 2013, Volume: 33, Issue:2

Topics: Amaryllidaceae Alkaloids; Animals; Apoptosis; Brain Neoplasms; Cohort Studies; Cytotoxins; Disease Models, Animal; Dose-Response Relationship, Drug; Glioblastoma; GTP Phosphohydrolases; Humans; In Vitro Techniques; Melanoma; Mice; Molecular Targeted Therapy; Neoplasms; Phenanthridines; Structure-Activity Relationship; Transplantation, Heterologous; Treatment Outcome

2013